BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16026414)

  • 1. Primary serous carcinoma of the peritoneum producing granulocyte colony-stimulating factor.
    Mikami M; Tanaka K; Komiyama S; Ishikawa M; Hirose T
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):820-2. PubMed ID: 16026414
    [No Abstract]   [Full Text] [Related]  

  • 2. Conservative surgery in a young patient with peritoneal psammocarcinoma.
    Munkarah AR; Jacques SM; Qureshi F; Deppe G
    Gynecol Oncol; 1999 May; 73(2):312-4. PubMed ID: 10329052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
    Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F
    Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT-1 and serous carcinoma.
    Wachtel MS
    Am J Surg Pathol; 2006 Jul; 30(7):921; author reply 921-2. PubMed ID: 16819342
    [No Abstract]   [Full Text] [Related]  

  • 5. Extraovarian peritoneal serous papillary carcinoma: a case report.
    Veroni S; Terzopoulou K; Anagnostopoulou I; Vassilakaki T; Grammatoglou X; Rammou R
    Acta Cytol; 2010; 54(5 Suppl):879-84. PubMed ID: 21053561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum.
    Seidman JD; Horkayne-Szakaly I; Cosin JA; Ryu HS; Haiba M; Boice CR; Yemelyanova AV
    Gynecol Oncol; 2006 Nov; 103(2):703-8. PubMed ID: 16828848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of pancreatic cancer with production of granulocyte colony-stimulating factor.
    Fukushima N; Sasatomi E; Tokunaga O; Miyahara M
    Am J Gastroenterol; 2001 Jan; 96(1):258-9. PubMed ID: 11197273
    [No Abstract]   [Full Text] [Related]  

  • 8. Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy.
    Vandenput I; Amant F; Vergote I
    Gynecol Oncol; 2005 Sep; 98(3):523; author reply 524-5. PubMed ID: 16054202
    [No Abstract]   [Full Text] [Related]  

  • 9. A successfully treated primary peritoneal carcinosarcoma and serous carcinoma of stage IIIC rescued from hypovolemic shock due to tumor rupture.
    Huang CC; Tsai HJ; Huang SH; Kok VC
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):296-297. PubMed ID: 30910157
    [No Abstract]   [Full Text] [Related]  

  • 10. Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?
    Roh MH; Kindelberger D; Crum CP
    Am J Surg Pathol; 2009 Mar; 33(3):376-83. PubMed ID: 19011565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrocystic serous cystadenocarcinoma of the pancreas: the first report of a new pattern of pancreatic carcinoma.
    Gupta R; Dinda AK; Singh MK; Misra MC
    J Clin Pathol; 2008 Mar; 61(3):396-8. PubMed ID: 18305183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
    Trahan S; TĂȘtu B; Raymond PE
    Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.
    Khalifeh I; Deavers MT; Cristofanilli M; Coleman RL; Malpica A; Gilcrease MZ
    Breast J; 2009; 15(2):176-81. PubMed ID: 19292804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
    Schmeler KM; Sun CC; Bodurka DC; Deavers MT; Malpica A; Coleman RL; Ramirez PT; Gershenson DM
    Gynecol Oncol; 2008 Mar; 108(3):510-4. PubMed ID: 18155273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting abnormal cells from primary serous peritoneal carcinoma by Pap smear.
    Wang PH; Yuan CC; Lai CR
    Acta Cytol; 1999; 43(6):1200-2. PubMed ID: 10579010
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of immunohistochemistry in differentiating between peritoneal mesothelioma and ovarian serous carcinoma.
    Al-Rawi HJ; Ben-Ghashir NS
    Saudi Med J; 2009 Apr; 30(4):571-4. PubMed ID: 19370292
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulocyte colony stimulating factor secreting hepatocellular carcinoma.
    Snyder RA; Liu E; Merchant NB
    Am Surg; 2012 Jul; 78(7):821-2. PubMed ID: 22748547
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.
    Hou T; Liang D; He J; Chen X; Zhang Y
    Int J Clin Exp Pathol; 2012; 5(8):762-9. PubMed ID: 23071858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary peritoneal psammocarcinoma.
    Afifi K; Thomas DH; Bhaumik J
    J Obstet Gynaecol; 2009 Jul; 29(5):453-4. PubMed ID: 19603339
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer.
    Chan JK; Lin SS; McMeekin DS; Berman ML
    J Clin Oncol; 2005 Sep; 23(27):6794-5. PubMed ID: 16170188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.